Jun Rong Wei
About Jun Rong Wei
Jun Rong Wei serves as the Director of Strategic Operations at the Center for Integrated Solutions for Infectious Diseases (CISID) at the Broad Institute of MIT and Harvard, a position he has held since 2022. He has extensive experience in research and operations, having worked in various capacities at prestigious institutions such as Harvard and Novartis.
Work at Broad Institute
Jun Rong Wei has been serving as the Director of Strategic Operations at the Broad Institute of MIT and Harvard since 2022. In this role, he oversees various strategic initiatives within the Center for Integrated Solutions for Infectious Diseases (CISID). His responsibilities include building scientific programs that ensure comprehensive coverage of significant topics in infectious diseases and maintaining a balance within the scientific community.
Previous Experience in Public Health
Before joining the Broad Institute, Jun Rong Wei worked at the Harvard T.H. Chan School of Public Health as a Research Scientist from 2018 to 2021. He managed platforms for innate immunity assays and barcoding analysis using next-generation sequencing (NGS). His earlier role at the Harvard School of Public Health included serving as a Research Associate in the Rubin lab from 2011 to 2012, and as a Postdoctoral Fellow from 2006 to 2011.
Experience at Novartis Institutes
Jun Rong Wei held multiple positions at Novartis Institutes for BioMedical Research. He worked as Investigator II from 2012 to 2016 and later as Investigator III from 2016 to 2018, both in Emeryville, CA. His work involved significant contributions to research and development in the field of biomedical science.
Laboratory Skills and Publications
Jun Rong Wei possesses strong laboratory skills, particularly in molecular biology and immunological assays. His expertise has contributed to a robust track record of scientific publications, reflecting his active engagement in research and development within the scientific community.
Regulatory Compliance Knowledge
Jun Rong Wei is familiar with Good Practice (GxP) procedures and regulatory environments, indicating a strong understanding of compliance in drug and vaccine development. This knowledge is crucial for ensuring that research and development activities meet the necessary regulatory standards.